nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Atorvastatin—AHR—stomach cancer	0.0129	1	CrCbGaD
Conivaptan—Sepsis—Docetaxel—stomach cancer	0.00335	0.00505	CcSEcCtD
Conivaptan—Phlebitis—Docetaxel—stomach cancer	0.00325	0.00491	CcSEcCtD
Conivaptan—Sepsis—Capecitabine—stomach cancer	0.00324	0.00489	CcSEcCtD
Conivaptan—Phlebitis—Capecitabine—stomach cancer	0.00314	0.00475	CcSEcCtD
Conivaptan—Pneumonia—Irinotecan—stomach cancer	0.00314	0.00474	CcSEcCtD
Conivaptan—Diarrhoea—Mitomycin—stomach cancer	0.00313	0.00474	CcSEcCtD
Conivaptan—Polyuria—Capecitabine—stomach cancer	0.00309	0.00466	CcSEcCtD
Conivaptan—Pneumonia—Fluorouracil—stomach cancer	0.003	0.00454	CcSEcCtD
Conivaptan—Infestation—Fluorouracil—stomach cancer	0.00299	0.00451	CcSEcCtD
Conivaptan—Infestation NOS—Fluorouracil—stomach cancer	0.00299	0.00451	CcSEcCtD
Conivaptan—Atrial fibrillation—Docetaxel—stomach cancer	0.00295	0.00446	CcSEcCtD
Conivaptan—Vomiting—Mitomycin—stomach cancer	0.00291	0.0044	CcSEcCtD
Conivaptan—Urinary tract infection—Fluorouracil—stomach cancer	0.0029	0.00439	CcSEcCtD
Conivaptan—Headache—Mitomycin—stomach cancer	0.00287	0.00434	CcSEcCtD
Conivaptan—Cardiac failure—Docetaxel—stomach cancer	0.00287	0.00433	CcSEcCtD
Conivaptan—Atrial fibrillation—Capecitabine—stomach cancer	0.00286	0.00432	CcSEcCtD
Conivaptan—Thirst—Capecitabine—stomach cancer	0.00285	0.0043	CcSEcCtD
Conivaptan—Hyponatraemia—Docetaxel—stomach cancer	0.00281	0.00424	CcSEcCtD
Conivaptan—Cardiac failure—Capecitabine—stomach cancer	0.00278	0.00419	CcSEcCtD
Conivaptan—Nausea—Mitomycin—stomach cancer	0.00272	0.00411	CcSEcCtD
Conivaptan—Hyponatraemia—Capecitabine—stomach cancer	0.00272	0.00411	CcSEcCtD
Conivaptan—Dehydration—Docetaxel—stomach cancer	0.0026	0.00393	CcSEcCtD
Conivaptan—Cardiac disorder—Irinotecan—stomach cancer	0.0026	0.00393	CcSEcCtD
Conivaptan—Orthostatic hypotension—Docetaxel—stomach cancer	0.00256	0.00386	CcSEcCtD
Conivaptan—Angiopathy—Irinotecan—stomach cancer	0.00254	0.00384	CcSEcCtD
Conivaptan—Mediastinal disorder—Irinotecan—stomach cancer	0.00252	0.00381	CcSEcCtD
Conivaptan—Dehydration—Capecitabine—stomach cancer	0.00252	0.00381	CcSEcCtD
Conivaptan—Urine output increased—Methotrexate—stomach cancer	0.00251	0.0038	CcSEcCtD
Conivaptan—Candida infection—Epirubicin—stomach cancer	0.00248	0.00375	CcSEcCtD
Conivaptan—Orthostatic hypotension—Capecitabine—stomach cancer	0.00247	0.00374	CcSEcCtD
Conivaptan—Hypokalaemia—Capecitabine—stomach cancer	0.00247	0.00373	CcSEcCtD
Conivaptan—Sepsis—Methotrexate—stomach cancer	0.00241	0.00364	CcSEcCtD
Conivaptan—Erythema—Fluorouracil—stomach cancer	0.00233	0.00353	CcSEcCtD
Conivaptan—Polyuria—Methotrexate—stomach cancer	0.0023	0.00347	CcSEcCtD
Conivaptan—Candida infection—Doxorubicin—stomach cancer	0.0023	0.00347	CcSEcCtD
Conivaptan—Sepsis—Epirubicin—stomach cancer	0.00226	0.00341	CcSEcCtD
Conivaptan—Anaemia—Irinotecan—stomach cancer	0.00225	0.0034	CcSEcCtD
Conivaptan—Phlebitis—Epirubicin—stomach cancer	0.00219	0.00331	CcSEcCtD
Conivaptan—Pneumonia—Docetaxel—stomach cancer	0.00217	0.00328	CcSEcCtD
Conivaptan—Anaemia—Fluorouracil—stomach cancer	0.00216	0.00326	CcSEcCtD
Conivaptan—Infestation NOS—Docetaxel—stomach cancer	0.00216	0.00326	CcSEcCtD
Conivaptan—Infestation—Docetaxel—stomach cancer	0.00216	0.00326	CcSEcCtD
Conivaptan—Hyperglycaemia—Capecitabine—stomach cancer	0.00211	0.00319	CcSEcCtD
Conivaptan—Hypertension—Irinotecan—stomach cancer	0.0021	0.00318	CcSEcCtD
Conivaptan—Pneumonia—Capecitabine—stomach cancer	0.0021	0.00317	CcSEcCtD
Conivaptan—Infestation—Capecitabine—stomach cancer	0.00209	0.00315	CcSEcCtD
Conivaptan—Infestation NOS—Capecitabine—stomach cancer	0.00209	0.00315	CcSEcCtD
Conivaptan—Sepsis—Doxorubicin—stomach cancer	0.00209	0.00315	CcSEcCtD
Conivaptan—Urinary tract infection—Capecitabine—stomach cancer	0.00203	0.00307	CcSEcCtD
Conivaptan—Phlebitis—Doxorubicin—stomach cancer	0.00203	0.00306	CcSEcCtD
Conivaptan—Confusional state—Irinotecan—stomach cancer	0.00201	0.00303	CcSEcCtD
Conivaptan—Haematuria—Capecitabine—stomach cancer	0.00199	0.00301	CcSEcCtD
Conivaptan—Infection—Irinotecan—stomach cancer	0.00198	0.00299	CcSEcCtD
Conivaptan—Nervous system disorder—Irinotecan—stomach cancer	0.00195	0.00295	CcSEcCtD
Conivaptan—Hypoglycaemia—Epirubicin—stomach cancer	0.00193	0.00292	CcSEcCtD
Conivaptan—Cardiac failure—Epirubicin—stomach cancer	0.00193	0.00292	CcSEcCtD
Conivaptan—Confusional state—Fluorouracil—stomach cancer	0.00192	0.0029	CcSEcCtD
Conivaptan—Urinary tract disorder—Docetaxel—stomach cancer	0.00191	0.00289	CcSEcCtD
Conivaptan—Oedema peripheral—Docetaxel—stomach cancer	0.00191	0.00288	CcSEcCtD
Conivaptan—Urethral disorder—Docetaxel—stomach cancer	0.0019	0.00287	CcSEcCtD
Conivaptan—Hyponatraemia—Epirubicin—stomach cancer	0.00189	0.00286	CcSEcCtD
Conivaptan—Infection—Fluorouracil—stomach cancer	0.00189	0.00286	CcSEcCtD
Conivaptan—Nervous system disorder—Fluorouracil—stomach cancer	0.00187	0.00282	CcSEcCtD
Conivaptan—Hypotension—Irinotecan—stomach cancer	0.00186	0.00281	CcSEcCtD
Conivaptan—Urinary tract disorder—Capecitabine—stomach cancer	0.00185	0.0028	CcSEcCtD
Conivaptan—Oedema peripheral—Capecitabine—stomach cancer	0.00185	0.00279	CcSEcCtD
Conivaptan—Urethral disorder—Capecitabine—stomach cancer	0.00184	0.00278	CcSEcCtD
Conivaptan—Insomnia—Irinotecan—stomach cancer	0.0018	0.00272	CcSEcCtD
Conivaptan—Cardiac disorder—Docetaxel—stomach cancer	0.0018	0.00271	CcSEcCtD
Conivaptan—Cardiac failure—Doxorubicin—stomach cancer	0.00179	0.0027	CcSEcCtD
Conivaptan—Hypoglycaemia—Doxorubicin—stomach cancer	0.00179	0.0027	CcSEcCtD
Conivaptan—Hypotension—Fluorouracil—stomach cancer	0.00178	0.00269	CcSEcCtD
Conivaptan—Angiopathy—Docetaxel—stomach cancer	0.00176	0.00265	CcSEcCtD
Conivaptan—Dehydration—Epirubicin—stomach cancer	0.00176	0.00265	CcSEcCtD
Conivaptan—Hyponatraemia—Doxorubicin—stomach cancer	0.00175	0.00265	CcSEcCtD
Conivaptan—Mediastinal disorder—Docetaxel—stomach cancer	0.00174	0.00264	CcSEcCtD
Conivaptan—Cardiac disorder—Capecitabine—stomach cancer	0.00174	0.00263	CcSEcCtD
Conivaptan—Orthostatic hypotension—Epirubicin—stomach cancer	0.00172	0.0026	CcSEcCtD
Conivaptan—Insomnia—Fluorouracil—stomach cancer	0.00172	0.0026	CcSEcCtD
Conivaptan—Hypokalaemia—Epirubicin—stomach cancer	0.00172	0.0026	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00172	0.0026	CcSEcCtD
Conivaptan—Pain—Irinotecan—stomach cancer	0.0017	0.00257	CcSEcCtD
Conivaptan—Constipation—Irinotecan—stomach cancer	0.0017	0.00257	CcSEcCtD
Conivaptan—Angiopathy—Capecitabine—stomach cancer	0.0017	0.00257	CcSEcCtD
Conivaptan—Mental disorder—Docetaxel—stomach cancer	0.0017	0.00256	CcSEcCtD
Conivaptan—Mediastinal disorder—Capecitabine—stomach cancer	0.00169	0.00255	CcSEcCtD
Conivaptan—Erythema—Docetaxel—stomach cancer	0.00169	0.00255	CcSEcCtD
Conivaptan—Malnutrition—Docetaxel—stomach cancer	0.00169	0.00255	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00165	0.00249	CcSEcCtD
Conivaptan—Mental disorder—Capecitabine—stomach cancer	0.00164	0.00248	CcSEcCtD
Conivaptan—Feeling abnormal—Irinotecan—stomach cancer	0.00164	0.00248	CcSEcCtD
Conivaptan—Erythema—Capecitabine—stomach cancer	0.00163	0.00247	CcSEcCtD
Conivaptan—Malnutrition—Capecitabine—stomach cancer	0.00163	0.00247	CcSEcCtD
Conivaptan—Pain—Fluorouracil—stomach cancer	0.00163	0.00246	CcSEcCtD
Conivaptan—Dehydration—Doxorubicin—stomach cancer	0.00162	0.00245	CcSEcCtD
Conivaptan—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00159	0.00241	CcSEcCtD
Conivaptan—Hypokalaemia—Doxorubicin—stomach cancer	0.00159	0.0024	CcSEcCtD
Conivaptan—Body temperature increased—Irinotecan—stomach cancer	0.00157	0.00238	CcSEcCtD
Conivaptan—Feeling abnormal—Fluorouracil—stomach cancer	0.00157	0.00237	CcSEcCtD
Conivaptan—Pneumonia—Methotrexate—stomach cancer	0.00156	0.00236	CcSEcCtD
Conivaptan—Anaemia—Docetaxel—stomach cancer	0.00156	0.00235	CcSEcCtD
Conivaptan—Infestation NOS—Methotrexate—stomach cancer	0.00155	0.00235	CcSEcCtD
Conivaptan—Infestation—Methotrexate—stomach cancer	0.00155	0.00235	CcSEcCtD
Conivaptan—Anaemia—Capecitabine—stomach cancer	0.00151	0.00228	CcSEcCtD
Conivaptan—Pollakiuria—Epirubicin—stomach cancer	0.00151	0.00228	CcSEcCtD
Conivaptan—Body temperature increased—Fluorouracil—stomach cancer	0.00151	0.00228	CcSEcCtD
Conivaptan—Haematuria—Methotrexate—stomach cancer	0.00148	0.00224	CcSEcCtD
Conivaptan—Hyperglycaemia—Epirubicin—stomach cancer	0.00147	0.00222	CcSEcCtD
Conivaptan—Pneumonia—Epirubicin—stomach cancer	0.00146	0.00221	CcSEcCtD
Conivaptan—Hypertension—Docetaxel—stomach cancer	0.00145	0.0022	CcSEcCtD
Conivaptan—Infestation NOS—Epirubicin—stomach cancer	0.00145	0.0022	CcSEcCtD
Conivaptan—Infestation—Epirubicin—stomach cancer	0.00145	0.0022	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00142	0.00215	CcSEcCtD
Conivaptan—Urinary tract infection—Epirubicin—stomach cancer	0.00141	0.00214	CcSEcCtD
Conivaptan—Hypertension—Capecitabine—stomach cancer	0.00141	0.00213	CcSEcCtD
Conivaptan—Dry mouth—Docetaxel—stomach cancer	0.0014	0.00212	CcSEcCtD
Conivaptan—Pollakiuria—Doxorubicin—stomach cancer	0.00139	0.00211	CcSEcCtD
Conivaptan—Haematuria—Epirubicin—stomach cancer	0.00139	0.0021	CcSEcCtD
Conivaptan—Confusional state—Docetaxel—stomach cancer	0.00139	0.0021	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00138	0.00208	CcSEcCtD
Conivaptan—Urinary tract disorder—Methotrexate—stomach cancer	0.00138	0.00208	CcSEcCtD
Conivaptan—Urethral disorder—Methotrexate—stomach cancer	0.00137	0.00207	CcSEcCtD
Conivaptan—Infection—Docetaxel—stomach cancer	0.00137	0.00206	CcSEcCtD
Conivaptan—Hyperglycaemia—Doxorubicin—stomach cancer	0.00136	0.00206	CcSEcCtD
Conivaptan—Diarrhoea—Irinotecan—stomach cancer	0.00136	0.00206	CcSEcCtD
Conivaptan—Dry mouth—Capecitabine—stomach cancer	0.00136	0.00205	CcSEcCtD
Conivaptan—Pneumonia—Doxorubicin—stomach cancer	0.00135	0.00205	CcSEcCtD
Conivaptan—Nervous system disorder—Docetaxel—stomach cancer	0.00135	0.00204	CcSEcCtD
Conivaptan—Pruritus—Fluorouracil—stomach cancer	0.00135	0.00204	CcSEcCtD
Conivaptan—Infestation—Doxorubicin—stomach cancer	0.00135	0.00203	CcSEcCtD
Conivaptan—Infestation NOS—Doxorubicin—stomach cancer	0.00135	0.00203	CcSEcCtD
Conivaptan—Confusional state—Capecitabine—stomach cancer	0.00134	0.00203	CcSEcCtD
Conivaptan—Skin disorder—Docetaxel—stomach cancer	0.00134	0.00202	CcSEcCtD
Conivaptan—Infection—Capecitabine—stomach cancer	0.00132	0.002	CcSEcCtD
Conivaptan—Urinary tract infection—Doxorubicin—stomach cancer	0.00131	0.00198	CcSEcCtD
Conivaptan—Nervous system disorder—Capecitabine—stomach cancer	0.00131	0.00197	CcSEcCtD
Conivaptan—Diarrhoea—Fluorouracil—stomach cancer	0.0013	0.00197	CcSEcCtD
Conivaptan—Cardiac disorder—Methotrexate—stomach cancer	0.00129	0.00196	CcSEcCtD
Conivaptan—Skin disorder—Capecitabine—stomach cancer	0.00129	0.00195	CcSEcCtD
Conivaptan—Urinary tract disorder—Epirubicin—stomach cancer	0.00129	0.00195	CcSEcCtD
Conivaptan—Oedema peripheral—Epirubicin—stomach cancer	0.00129	0.00194	CcSEcCtD
Conivaptan—Hypotension—Docetaxel—stomach cancer	0.00129	0.00194	CcSEcCtD
Conivaptan—Haematuria—Doxorubicin—stomach cancer	0.00128	0.00194	CcSEcCtD
Conivaptan—Urethral disorder—Epirubicin—stomach cancer	0.00128	0.00193	CcSEcCtD
Conivaptan—Angiopathy—Methotrexate—stomach cancer	0.00127	0.00191	CcSEcCtD
Conivaptan—Vomiting—Irinotecan—stomach cancer	0.00126	0.00191	CcSEcCtD
Conivaptan—Mediastinal disorder—Methotrexate—stomach cancer	0.00126	0.0019	CcSEcCtD
Conivaptan—Headache—Irinotecan—stomach cancer	0.00125	0.00188	CcSEcCtD
Conivaptan—Hypotension—Capecitabine—stomach cancer	0.00124	0.00188	CcSEcCtD
Conivaptan—Insomnia—Docetaxel—stomach cancer	0.00124	0.00188	CcSEcCtD
Conivaptan—Mental disorder—Methotrexate—stomach cancer	0.00122	0.00185	CcSEcCtD
Conivaptan—Malnutrition—Methotrexate—stomach cancer	0.00121	0.00184	CcSEcCtD
Conivaptan—Erythema—Methotrexate—stomach cancer	0.00121	0.00184	CcSEcCtD
Conivaptan—Cardiac disorder—Epirubicin—stomach cancer	0.00121	0.00183	CcSEcCtD
Conivaptan—Vomiting—Fluorouracil—stomach cancer	0.00121	0.00183	CcSEcCtD
Conivaptan—Insomnia—Capecitabine—stomach cancer	0.0012	0.00182	CcSEcCtD
Conivaptan—Headache—Fluorouracil—stomach cancer	0.00119	0.0018	CcSEcCtD
Conivaptan—Urinary tract disorder—Doxorubicin—stomach cancer	0.00119	0.0018	CcSEcCtD
Conivaptan—Oedema peripheral—Doxorubicin—stomach cancer	0.00119	0.0018	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00119	0.00179	CcSEcCtD
Conivaptan—Angiopathy—Epirubicin—stomach cancer	0.00118	0.00179	CcSEcCtD
Conivaptan—Urethral disorder—Doxorubicin—stomach cancer	0.00118	0.00179	CcSEcCtD
Conivaptan—Nausea—Irinotecan—stomach cancer	0.00118	0.00179	CcSEcCtD
Conivaptan—Mediastinal disorder—Epirubicin—stomach cancer	0.00118	0.00178	CcSEcCtD
Conivaptan—Pain—Docetaxel—stomach cancer	0.00118	0.00178	CcSEcCtD
Conivaptan—Constipation—Docetaxel—stomach cancer	0.00118	0.00178	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00115	0.00174	CcSEcCtD
Conivaptan—Mental disorder—Epirubicin—stomach cancer	0.00114	0.00173	CcSEcCtD
Conivaptan—Pain—Capecitabine—stomach cancer	0.00114	0.00172	CcSEcCtD
Conivaptan—Constipation—Capecitabine—stomach cancer	0.00114	0.00172	CcSEcCtD
Conivaptan—Erythema—Epirubicin—stomach cancer	0.00114	0.00172	CcSEcCtD
Conivaptan—Malnutrition—Epirubicin—stomach cancer	0.00114	0.00172	CcSEcCtD
Conivaptan—Feeling abnormal—Docetaxel—stomach cancer	0.00113	0.00171	CcSEcCtD
Conivaptan—Nausea—Fluorouracil—stomach cancer	0.00113	0.00171	CcSEcCtD
Conivaptan—Anaemia—Methotrexate—stomach cancer	0.00112	0.0017	CcSEcCtD
Conivaptan—Cardiac disorder—Doxorubicin—stomach cancer	0.00112	0.00169	CcSEcCtD
Conivaptan—Feeling abnormal—Capecitabine—stomach cancer	0.0011	0.00166	CcSEcCtD
Conivaptan—Angiopathy—Doxorubicin—stomach cancer	0.0011	0.00166	CcSEcCtD
Conivaptan—Mediastinal disorder—Doxorubicin—stomach cancer	0.00109	0.00165	CcSEcCtD
Conivaptan—Body temperature increased—Docetaxel—stomach cancer	0.00109	0.00164	CcSEcCtD
Conivaptan—Mental disorder—Doxorubicin—stomach cancer	0.00106	0.0016	CcSEcCtD
Conivaptan—Body temperature increased—Capecitabine—stomach cancer	0.00105	0.00159	CcSEcCtD
Conivaptan—Malnutrition—Doxorubicin—stomach cancer	0.00105	0.00159	CcSEcCtD
Conivaptan—Erythema—Doxorubicin—stomach cancer	0.00105	0.00159	CcSEcCtD
Conivaptan—Anaemia—Epirubicin—stomach cancer	0.00105	0.00159	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00103	0.00155	CcSEcCtD
Conivaptan—Confusional state—Methotrexate—stomach cancer	0.000999	0.00151	CcSEcCtD
Conivaptan—Infection—Methotrexate—stomach cancer	0.000985	0.00149	CcSEcCtD
Conivaptan—Hypertension—Epirubicin—stomach cancer	0.000981	0.00148	CcSEcCtD
Conivaptan—Pruritus—Docetaxel—stomach cancer	0.000973	0.00147	CcSEcCtD
Conivaptan—Nervous system disorder—Methotrexate—stomach cancer	0.000972	0.00147	CcSEcCtD
Conivaptan—Anaemia—Doxorubicin—stomach cancer	0.000972	0.00147	CcSEcCtD
Conivaptan—Skin disorder—Methotrexate—stomach cancer	0.000963	0.00145	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000961	0.00145	CcSEcCtD
Conivaptan—Dry mouth—Epirubicin—stomach cancer	0.000946	0.00143	CcSEcCtD
Conivaptan—Pruritus—Capecitabine—stomach cancer	0.000942	0.00142	CcSEcCtD
Conivaptan—Diarrhoea—Docetaxel—stomach cancer	0.000941	0.00142	CcSEcCtD
Conivaptan—Confusional state—Epirubicin—stomach cancer	0.000935	0.00141	CcSEcCtD
Conivaptan—Hypotension—Methotrexate—stomach cancer	0.000926	0.0014	CcSEcCtD
Conivaptan—Infection—Epirubicin—stomach cancer	0.000922	0.00139	CcSEcCtD
Conivaptan—Diarrhoea—Capecitabine—stomach cancer	0.000911	0.00138	CcSEcCtD
Conivaptan—Nervous system disorder—Epirubicin—stomach cancer	0.00091	0.00137	CcSEcCtD
Conivaptan—Hypertension—Doxorubicin—stomach cancer	0.000908	0.00137	CcSEcCtD
Conivaptan—Skin disorder—Epirubicin—stomach cancer	0.000901	0.00136	CcSEcCtD
Conivaptan—Insomnia—Methotrexate—stomach cancer	0.000897	0.00135	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000889	0.00134	CcSEcCtD
Conivaptan—Dry mouth—Doxorubicin—stomach cancer	0.000876	0.00132	CcSEcCtD
Conivaptan—Vomiting—Docetaxel—stomach cancer	0.000874	0.00132	CcSEcCtD
Conivaptan—Hypotension—Epirubicin—stomach cancer	0.000867	0.00131	CcSEcCtD
Conivaptan—Confusional state—Doxorubicin—stomach cancer	0.000865	0.00131	CcSEcCtD
Conivaptan—Headache—Docetaxel—stomach cancer	0.000862	0.0013	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000856	0.00129	CcSEcCtD
Conivaptan—Infection—Doxorubicin—stomach cancer	0.000853	0.00129	CcSEcCtD
Conivaptan—Pain—Methotrexate—stomach cancer	0.000848	0.00128	CcSEcCtD
Conivaptan—Vomiting—Capecitabine—stomach cancer	0.000847	0.00128	CcSEcCtD
Conivaptan—Nervous system disorder—Doxorubicin—stomach cancer	0.000842	0.00127	CcSEcCtD
Conivaptan—Insomnia—Epirubicin—stomach cancer	0.000839	0.00127	CcSEcCtD
Conivaptan—Headache—Capecitabine—stomach cancer	0.000834	0.00126	CcSEcCtD
Conivaptan—Skin disorder—Doxorubicin—stomach cancer	0.000834	0.00126	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—RGS2—stomach cancer	0.000831	0.00255	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GAST—stomach cancer	0.000831	0.00255	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RGS2—stomach cancer	0.000825	0.00254	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GAST—stomach cancer	0.000825	0.00254	CbGpPWpGaD
Conivaptan—Nausea—Docetaxel—stomach cancer	0.000817	0.00123	CcSEcCtD
Conivaptan—Feeling abnormal—Methotrexate—stomach cancer	0.000817	0.00123	CcSEcCtD
Conivaptan—Hypotension—Doxorubicin—stomach cancer	0.000802	0.00121	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000801	0.00121	CcSEcCtD
Conivaptan—Constipation—Epirubicin—stomach cancer	0.000793	0.0012	CcSEcCtD
Conivaptan—Pain—Epirubicin—stomach cancer	0.000793	0.0012	CcSEcCtD
Conivaptan—Nausea—Capecitabine—stomach cancer	0.000791	0.0012	CcSEcCtD
Conivaptan—Body temperature increased—Methotrexate—stomach cancer	0.000784	0.00118	CcSEcCtD
Conivaptan—Insomnia—Doxorubicin—stomach cancer	0.000776	0.00117	CcSEcCtD
Conivaptan—Feeling abnormal—Epirubicin—stomach cancer	0.000764	0.00116	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000741	0.00112	CcSEcCtD
Conivaptan—Constipation—Doxorubicin—stomach cancer	0.000734	0.00111	CcSEcCtD
Conivaptan—Pain—Doxorubicin—stomach cancer	0.000734	0.00111	CcSEcCtD
Conivaptan—Body temperature increased—Epirubicin—stomach cancer	0.000733	0.00111	CcSEcCtD
Conivaptan—Feeling abnormal—Doxorubicin—stomach cancer	0.000707	0.00107	CcSEcCtD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000704	0.00216	CbGpPWpGaD
Conivaptan—Pruritus—Methotrexate—stomach cancer	0.000701	0.00106	CcSEcCtD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000695	0.00214	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGTR2—stomach cancer	0.000693	0.00213	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—WWOX—stomach cancer	0.000689	0.00212	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGTR2—stomach cancer	0.000688	0.00212	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—F2R—stomach cancer	0.000686	0.00211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—WWOX—stomach cancer	0.000684	0.0021	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—F2R—stomach cancer	0.000681	0.00209	CbGpPWpGaD
Conivaptan—Body temperature increased—Doxorubicin—stomach cancer	0.000678	0.00103	CcSEcCtD
Conivaptan—Diarrhoea—Methotrexate—stomach cancer	0.000678	0.00102	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR1A—stomach cancer	0.000667	0.00205	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR1A—stomach cancer	0.000663	0.00204	CbGpPWpGaD
Conivaptan—Pruritus—Epirubicin—stomach cancer	0.000656	0.000992	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000652	0.002	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ANXA1—stomach cancer	0.000645	0.00198	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRH4—stomach cancer	0.00064	0.00197	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—WIF1—stomach cancer	0.00064	0.00197	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ANXA1—stomach cancer	0.00064	0.00197	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRH4—stomach cancer	0.000636	0.00195	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—WIF1—stomach cancer	0.000636	0.00195	CbGpPWpGaD
Conivaptan—Diarrhoea—Epirubicin—stomach cancer	0.000635	0.000959	CcSEcCtD
Conivaptan—Vomiting—Methotrexate—stomach cancer	0.00063	0.000952	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—AGTR2—stomach cancer	0.00063	0.00194	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGTR2—stomach cancer	0.000625	0.00192	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB1—stomach cancer	0.000624	0.00192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—F2R—stomach cancer	0.000623	0.00191	CbGpPWpGaD
Conivaptan—Headache—Methotrexate—stomach cancer	0.000621	0.000938	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB1—stomach cancer	0.00062	0.00191	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—F2R—stomach cancer	0.000618	0.0019	CbGpPWpGaD
Conivaptan—Pruritus—Doxorubicin—stomach cancer	0.000607	0.000918	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—HTR1A—stomach cancer	0.000606	0.00186	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR1A—stomach cancer	0.000602	0.00185	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKAB1—stomach cancer	0.000591	0.00182	CbGpPWpGaD
Conivaptan—Vomiting—Epirubicin—stomach cancer	0.00059	0.000891	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000589	0.00181	CbGpPWpGaD
Conivaptan—Nausea—Methotrexate—stomach cancer	0.000589	0.00089	CcSEcCtD
Conivaptan—Diarrhoea—Doxorubicin—stomach cancer	0.000587	0.000887	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—PRKAB1—stomach cancer	0.000587	0.0018	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ANXA1—stomach cancer	0.000585	0.0018	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ANXA1—stomach cancer	0.000581	0.00179	CbGpPWpGaD
Conivaptan—Headache—Epirubicin—stomach cancer	0.000581	0.000878	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—RNF43—stomach cancer	0.000571	0.00175	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KISS1—stomach cancer	0.000571	0.00175	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000571	0.00175	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000568	0.00175	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB1—stomach cancer	0.000567	0.00174	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RNF43—stomach cancer	0.000567	0.00174	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KISS1—stomach cancer	0.000567	0.00174	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000564	0.00173	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB1—stomach cancer	0.000563	0.00173	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.00056	0.00172	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.00056	0.00172	CbGpPWpGaD
Conivaptan—Nausea—Epirubicin—stomach cancer	0.000551	0.000833	CcSEcCtD
Conivaptan—Vomiting—Doxorubicin—stomach cancer	0.000546	0.000825	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000544	0.00167	CbGpPWpGaD
Conivaptan—Headache—Doxorubicin—stomach cancer	0.000538	0.000812	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000529	0.00163	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000512	0.00157	CbGpPWpGaD
Conivaptan—Nausea—Doxorubicin—stomach cancer	0.00051	0.00077	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—FST—stomach cancer	0.000509	0.00156	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB2—stomach cancer	0.000506	0.00155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FST—stomach cancer	0.000505	0.00155	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB2—stomach cancer	0.000502	0.00154	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HBEGF—stomach cancer	0.000498	0.00153	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000494	0.00152	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HBEGF—stomach cancer	0.000494	0.00152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RGS2—stomach cancer	0.000491	0.00151	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GAST—stomach cancer	0.000491	0.00151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GAST—stomach cancer	0.000487	0.0015	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RGS2—stomach cancer	0.000487	0.0015	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000486	0.00149	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGG—stomach cancer	0.000465	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGG—stomach cancer	0.000462	0.00142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB2—stomach cancer	0.000459	0.00141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB2—stomach cancer	0.000456	0.0014	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PPP2R1A—stomach cancer	0.00045	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.00045	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKAA1—stomach cancer	0.000448	0.00138	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000447	0.00137	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKAA1—stomach cancer	0.000445	0.00137	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RBP4—stomach cancer	0.000433	0.00133	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL8—stomach cancer	0.000432	0.00133	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000431	0.00132	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RBP4—stomach cancer	0.000429	0.00132	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL8—stomach cancer	0.000429	0.00132	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—stomach cancer	0.000392	0.0012	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HSPB1—stomach cancer	0.000372	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGTR2—stomach cancer	0.000372	0.00114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HSPB1—stomach cancer	0.000369	0.00114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR2—stomach cancer	0.000369	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BMP2—stomach cancer	0.000368	0.00113	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—F2R—stomach cancer	0.000368	0.00113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—F2R—stomach cancer	0.000365	0.00112	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BMP2—stomach cancer	0.000365	0.00112	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKR1C3—stomach cancer	0.000362	0.00111	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKR1C3—stomach cancer	0.000359	0.0011	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1A—stomach cancer	0.000358	0.0011	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1A—stomach cancer	0.000355	0.00109	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PRKCB—stomach cancer	0.000347	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ANXA1—stomach cancer	0.000346	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PRKCB—stomach cancer	0.000344	0.00106	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ANXA1—stomach cancer	0.000343	0.00106	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB1—stomach cancer	0.000335	0.00103	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB1—stomach cancer	0.000332	0.00102	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RPS6—stomach cancer	0.00032	0.000984	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RPS6—stomach cancer	0.000318	0.000976	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PRKCB—stomach cancer	0.000315	0.000968	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6ST—stomach cancer	0.000314	0.000964	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PRKCB—stomach cancer	0.000313	0.000961	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6ST—stomach cancer	0.000311	0.000957	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000307	0.000943	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000303	0.000932	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HBEGF—stomach cancer	0.000294	0.000904	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HBEGF—stomach cancer	0.000292	0.000897	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000291	0.000894	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6R—stomach cancer	0.00028	0.00086	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—RHOA—stomach cancer	0.000278	0.000855	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6R—stomach cancer	0.000278	0.000854	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—RHOA—stomach cancer	0.000276	0.000849	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—stomach cancer	0.000271	0.000834	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—stomach cancer	0.000269	0.000828	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PPP2R1A—stomach cancer	0.000266	0.000817	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP2R1A—stomach cancer	0.000264	0.000812	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—RHOA—stomach cancer	0.000253	0.000777	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RHOA—stomach cancer	0.000251	0.000771	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SMAD4—stomach cancer	0.000247	0.000759	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SMAD4—stomach cancer	0.000245	0.000754	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—stomach cancer	0.000244	0.000751	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—stomach cancer	0.000243	0.000746	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FYN—stomach cancer	0.000234	0.000721	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FYN—stomach cancer	0.000233	0.000715	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—stomach cancer	0.000222	0.000682	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—stomach cancer	0.00022	0.000677	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGFR2—stomach cancer	0.00022	0.000676	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGFR2—stomach cancer	0.000218	0.000672	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—stomach cancer	0.000213	0.000653	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	0.00021	0.000644	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS2—stomach cancer	0.000202	0.000619	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS2—stomach cancer	0.0002	0.000615	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CAV1—stomach cancer	0.000195	0.000601	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—stomach cancer	0.000195	0.0006	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—stomach cancer	0.000195	0.000599	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CAV1—stomach cancer	0.000194	0.000596	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—stomach cancer	0.000194	0.000595	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	0.000193	0.000592	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRKCB—stomach cancer	0.000186	0.000572	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6ST—stomach cancer	0.000185	0.000569	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRKCB—stomach cancer	0.000185	0.000568	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6ST—stomach cancer	0.000184	0.000565	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ACAD8—stomach cancer	0.000183	0.000562	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APC—stomach cancer	0.000178	0.000547	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APC—stomach cancer	0.000177	0.000543	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK3—stomach cancer	0.00017	0.000524	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK3—stomach cancer	0.000169	0.00052	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6R—stomach cancer	0.000165	0.000508	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6R—stomach cancer	0.000164	0.000504	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GMPR2—stomach cancer	0.000163	0.000501	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MAPK1—stomach cancer	0.000162	0.000499	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EGFR—stomach cancer	0.000162	0.000498	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MAPK1—stomach cancer	0.000161	0.000495	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EGFR—stomach cancer	0.000161	0.000495	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PIK3CA—stomach cancer	0.000155	0.000476	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—stomach cancer	0.000155	0.000476	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PIK3CA—stomach cancer	0.000154	0.000473	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—stomach cancer	0.000154	0.000472	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—KRAS—stomach cancer	0.000153	0.000471	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KRAS—stomach cancer	0.000152	0.000467	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RHOA—stomach cancer	0.000149	0.000459	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SUCLG1—stomach cancer	0.000149	0.000458	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—IDH3B—stomach cancer	0.000149	0.000458	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RHOA—stomach cancer	0.000148	0.000456	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—stomach cancer	0.000148	0.000454	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—stomach cancer	0.000147	0.000451	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PIK3CA—stomach cancer	0.000141	0.000433	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PIK3CA—stomach cancer	0.00014	0.000429	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NDUFV1—stomach cancer	0.000138	0.000426	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NDUFS1—stomach cancer	0.000138	0.000426	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ERBB2—stomach cancer	0.000138	0.000425	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ERBB2—stomach cancer	0.000137	0.000422	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—stomach cancer	0.000131	0.000403	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRAS—stomach cancer	0.00013	0.0004	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—stomach cancer	0.00013	0.0004	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRAS—stomach cancer	0.000129	0.000397	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1B—stomach cancer	0.000128	0.000393	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1B—stomach cancer	0.000127	0.000391	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—stomach cancer	0.000125	0.000383	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—stomach cancer	0.000124	0.00038	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—BLVRB—stomach cancer	0.000123	0.000379	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PGLS—stomach cancer	0.000123	0.000379	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCND1—stomach cancer	0.000122	0.000375	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—JUN—stomach cancer	0.000122	0.000375	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCND1—stomach cancer	0.000121	0.000373	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—JUN—stomach cancer	0.000121	0.000372	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—stomach cancer	0.000119	0.000364	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CDKN1A—stomach cancer	0.000118	0.000363	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPAP2A—stomach cancer	0.000118	0.000362	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—stomach cancer	0.000118	0.000362	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CDKN1A—stomach cancer	0.000117	0.00036	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK8—stomach cancer	0.000115	0.000354	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK8—stomach cancer	0.000114	0.000352	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—stomach cancer	0.000106	0.000327	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—stomach cancer	0.000106	0.000325	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—stomach cancer	0.000105	0.000324	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FBP1—stomach cancer	0.000105	0.000323	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CKB—stomach cancer	0.000105	0.000323	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA1—stomach cancer	0.000105	0.000323	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NDUFA2—stomach cancer	0.000105	0.000323	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—stomach cancer	0.000105	0.000322	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK3—stomach cancer	0.000101	0.00031	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK3—stomach cancer	0.0001	0.000307	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLIN2—stomach cancer	9.87e-05	0.000303	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MYC—stomach cancer	9.79e-05	0.000301	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MYC—stomach cancer	9.72e-05	0.000299	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CA2—stomach cancer	9.6e-05	0.000295	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MAPK1—stomach cancer	9.58e-05	0.000295	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGFR—stomach cancer	9.58e-05	0.000294	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MAPK1—stomach cancer	9.51e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGFR—stomach cancer	9.51e-05	0.000292	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NT5E—stomach cancer	9.35e-05	0.000288	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PGAM1—stomach cancer	9.35e-05	0.000288	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KRAS—stomach cancer	9.05e-05	0.000278	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KRAS—stomach cancer	8.98e-05	0.000276	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	8.92e-05	0.000274	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLCE1—stomach cancer	8.92e-05	0.000274	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—UMPS—stomach cancer	8.56e-05	0.000263	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PIK3CA—stomach cancer	8.31e-05	0.000256	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PIK3CA—stomach cancer	8.25e-05	0.000254	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TP53—stomach cancer	8.04e-05	0.000247	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TP53—stomach cancer	7.98e-05	0.000245	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PDHA1—stomach cancer	7.95e-05	0.000244	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ECHS1—stomach cancer	7.95e-05	0.000244	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRAS—stomach cancer	7.69e-05	0.000236	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRAS—stomach cancer	7.64e-05	0.000235	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TYMP—stomach cancer	7.48e-05	0.00023	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FADS1—stomach cancer	7.48e-05	0.00023	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—stomach cancer	7.36e-05	0.000226	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—stomach cancer	7.31e-05	0.000225	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF2—stomach cancer	7e-05	0.000215	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—RORA—stomach cancer	6.92e-05	0.000213	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDOB—stomach cancer	6.48e-05	0.000199	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX5—stomach cancer	6.03e-05	0.000185	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DPYD—stomach cancer	5.93e-05	0.000182	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—stomach cancer	5.24e-05	0.000161	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.18e-05	0.000159	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.04e-05	0.000155	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ENO1—stomach cancer	4.91e-05	0.000151	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD44—stomach cancer	4.36e-05	0.000134	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.71e-05	0.000114	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—stomach cancer	3.63e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—stomach cancer	3.58e-05	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TYMS—stomach cancer	3.38e-05	0.000104	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—stomach cancer	3.34e-05	0.000103	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ERCC2—stomach cancer	3.14e-05	9.65e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—stomach cancer	2.95e-05	9.07e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAV1—stomach cancer	2.72e-05	8.37e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—stomach cancer	2.72e-05	8.35e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—stomach cancer	2.39e-05	7.36e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—stomach cancer	2.15e-05	6.62e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—stomach cancer	2.06e-05	6.33e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—stomach cancer	1.88e-05	5.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.16e-05	3.56e-05	CbGpPWpGaD
